Anglo-Swedish pharma major AstraZeneca closed Thursday’s trading 3% higher, as investors digested its third quarter financial ...

US biopharma company Ultragenyx Pharmaceutical today announced the sale, for $400 million, of an additional 25% of the ...

South Korea’s Samsung Bioepis. has signed a settlement and license agreement with Johnson & Johnson concerning the ...

The Russian government has approved the allocation of 140 billion roubles ($1.72 billion) annually for the treatment of ...

US mRNA-based therapeutics company Strand Therapeutics has announced the promotion of Prashant Nambiar to chief scientific ...

Arena BioWorks, a privately funded biomedical research institute that aimed to overhaul the traditional drug discovery model, ...

The zero-gravity environment of orbit is emerging as a new frontier for biopharmaceutical innovation. According to GlobalData ...

Australian biotech PolyActiva and USA-based RareSight have formed a strategic collaboration to create first-in-class ...

California, USA-based clinical-stage biotech Braveheart Bio has announced its launch with $185 million in Series A financing, ...

A biotech company developing in-body genome engineering therapies to program a patient’s own T cells directly within the body ...

A Delaware vice chancellor on Wednesday refused Pfizer emergency bid for a temporary restraining order to block Metsera from ...

Shares of US clinical-stage biopharma Biohaven plunged more than 40% to $8.34 yesterday, after it announced that it has ...